| Literature DB >> 24432223 |
Joana Cortez1, Bruno Costa Gomes2, Andrea Speidel1, Conceição Peixoto3, Elina Selicka4, Cristina Valente1, Paulo Figueiredo5, António Vieira1.
Abstract
Mucormycosis is an emergent and threatening invasive fungal invasion underdiagnosed by clinicians due to lack of awareness and aspecific clinical picture. The authors describe a clinical case of a diabetic and cirrhotic patient who developed rhino-orbital-cerebral and pulmonary mucormycosis, non-responsive to treatment. Typical gaps in the management of this deadly disease are addressed. There is a strong need for novel therapies and an expectation that sponsors will recognize the critical need for randomized clinical trials.Entities:
Keywords: Delays; Diabetes; High mortality; Hyperbaric medicine; Mucormycosis; Randomized clinical trials
Year: 2013 PMID: 24432223 PMCID: PMC3885946 DOI: 10.1016/j.mmcr.2013.02.008
Source DB: PubMed Journal: Med Mycol Case Rep ISSN: 2211-7539